<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/60B5B580-A39F-40E7-9A81-BAF364F8AED6"><gtr:id>60B5B580-A39F-40E7-9A81-BAF364F8AED6</gtr:id><gtr:name>Diagnostig Ltd</gtr:name><gtr:address><gtr:line1>School Of Chemistry,Deiniol Road</gtr:line1><gtr:city>Bangor</gtr:city><gtr:postCode>LL57 2UW</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60B5B580-A39F-40E7-9A81-BAF364F8AED6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>60B5B580-A39F-40E7-9A81-BAF364F8AED6</gtr:id><gtr:name>Diagnostig Ltd</gtr:name><gtr:address><gtr:line1>School Of Chemistry,Deiniol Road</gtr:line1><gtr:city>Bangor</gtr:city><gtr:postCode>LL57 2UW</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>15000.0</gtr:offerGrant><gtr:projectCost>25000.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BBE92918-6A5E-4939-A4FD-CD5AD3102B5A"><gtr:id>BBE92918-6A5E-4939-A4FD-CD5AD3102B5A</gtr:id><gtr:firstName>mark</gtr:firstName><gtr:surname>baird</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=700561"><gtr:id>9894E573-138F-4EFC-8839-162F5E77828E</gtr:id><gtr:title>A new approach to point of assessment diagnosis of tuberculosis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>GRD Proof of Market</gtr:grantCategory><gtr:grantReference>700561</gtr:grantReference><gtr:abstractText>We have developed a novel device for the detection of TB which works in under 30 minutes;
this is based on the recognition of unique molecules identical to components of the cell walls
of mycobacteria by antibodies present in the serum of individuals with active TB. The target
set by the World Health Organisation is for a field device that works rapidly and reliably and
can be sold in high burden TB countries for around $ 5 - 10; our current device works in 15
minutes, does not require electricity or a specialist laboratory, and is expected to meet the cost
criteria. We already have some patent protection applied for and need to confirm that we can
obtain proper protection for a number of new disclosures. We need to validate our method in
comparison with other devices currently available for use in a laboratory and which generally
take several hours to provide a result, and to compare our method with the 'gold standard' of
cell culture, that can take several weeks to provide a result. With this information to hand, we
need to develop a detailed plan for the route to market, including the development of strict
product specifications, quality control systems, and a strategy for achieving recognition by
Government Agencies and bodies such as the WHO. If we can optimise the device, gain such
recognition and meet the challenges of market penetration, a conservative estimate of the
market need for such a device in high burden TB countries alone is some 50 million units per
annum.</gtr:abstractText><gtr:fund><gtr:end>2015-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>15000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">700561</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>